Date | Company | Who recommends | Recommendation | Target price |
---|---|---|---|---|
Vertex Pharmaceuticals Incorporated | Argus | Buy | 155 | |
Stryker Corporation | Argus | Buy | 120 | |
Thermo Fisher Scientific, Inc. | Argus | Buy | 145 | |
Universal Health Services Inc. | Barclays | Buy | 150 | |
Mallinckrodt Public Limited Company | Barclays | Buy | 80 | |
Abbott Laboratories | Barclays | Buy | 52 | |
Regeneron Pharmaceuticals, Inc. | Barclays | Buy | 593 | |
Mylan N.V. | Barclays | Buy | 57 | |
Humana Inc. | Barclays | Buy | 223 | |
Cigna Corp. | Barclays | Buy | 156 | |
Intuitive Surgical, Inc. | Barclays | Buy | 625 | |
Biogen Inc. | Bernstein | Buy | 360 | |
Eli Lilly and Company | BofA/Merrill | Buy | 90 | |
Waters Corporation | BofA/Merrill | Buy | 140 | |
Aetna Inc. | BofA/Merrill | Buy | 162 | |
Amgen Inc. | Deutsche Bank | Buy | 180 | |
Allergan plc | Deutsche Bank | Buy | 342 | |
Boston Scientific Corporation | Deutsche Bank | Buy | 22 | |
Gilead Sciences Inc. | Deutsche Bank | Buy | 124 | |
St. Jude Medical Inc. | Deutsche Bank | Buy | 77 |